This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Laboratorios Almirall, S.a.. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saragossa, ES (2009)
- Zaragoza, ES (2011)
Company Filing History:
Years Active: 2009-2011
Title: Yolanda Garrido Rubio: Pioneering PDE4 Inhibitors for Therapeutic Advancements
Introduction
Yolanda Garrido Rubio is an innovative inventor based in Zaragoza, Spain, known for her contributions to the field of pharmaceuticals. With a total of 2 patents registered, her work primarily focuses on developing new therapeutically useful compounds that can significantly improve the treatment of various diseases.
Latest Patents
Yolanda's latest patents involve the invention of new pyridazin-3(2H)-one derivatives, which are characterized by their potent and selective inhibition of phosphodiesterase 4 (PDE4). These derivatives hold promise for treating conditions such as asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, atopic dermatitis, psoriasis, and irritable bowel disease. The patents detail not only the chemical formulations but also the processes for their preparation and their use in pharmaceutical compositions aimed at improving patient outcomes.
Career Highlights
Currently, Yolanda is employed at Laboratorios Almirall, S.A., a company dedicated to developing medications that address unmet patient needs. Her expertise in medicinal chemistry has earned her recognition in the field, as she continually seeks to innovate and expand the therapeutic potential of her inventions.
Collaborations
Throughout her career, Yolanda has collaborated with notable colleagues, including Vittorio Dal Piaz and Jordi Gracia Ferrer. Their combined efforts have fostered an environment of creativity and scientific advancement, leading to breakthroughs in pharmacological research aimed at improving quality of life for patients suffering from chronic illnesses.
Conclusion
Yolanda Garrido Rubio stands out as a forward-thinking inventor whose work has the potential to revolutionize the treatment of several prevalent diseases. Through her innovative patents and collaborations, she continues to make a significant impact on the pharmaceutical industry, paving the way for new therapeutic strategies and improved patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
